Weekly CEO Buy Highlights: Helix Energy Solutions Group Inc, Optimer Pharmaceuticals Inc, Keithley Instruments Inc.

Weekly CEO Buy Highlights: HLX, OPTR, KEI

Author's Avatar
Jan 02, 2010
According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Helix Energy Solutions Group Inc. (HLX, Financial): PRESIDENT & CEO Owen E Kratz Bought 100,000 Shares

PRESIDENT & CEO of Helix Energy Solutions Group Inc. (HLX) Owen E Kratz bought 100,000 shares on 12/30/2009 at an average price of $11.75. Helix Energy Solutions Group Inc., is a leading marine contractor and operator of offshore oil and gas properties and production facilities. The company has a market cap of $1.23 billion; its shares were traded at around $11.75 with a P/E ratio of 21.1 and P/S ratio of 0.6. Helix Energy Solutions Group Inc. had an annual average earning growth of 28.6% over the past 10 years.

Helix recently reported its third quarter results. The company reported net income of $3.9 million or $0.04 per diluted share, for the third quarter of 2009 compared with net income of $59.3 million, or $0.63 per diluted share, for the same period in 2008, and net income of $100.2 million, or $0.94 per diluted share, in the second quarter of 2009. Net income for the nine months ended September 30, 2009 was $157.6 million, or $1.48 per diluted share, compared with $222.0 million, or $2.34 per diluted share, for the nine months ended September 30, 2008.

George Soros bought 21,000 shares in the quarter that ended on 09/30/2009, which is 0.01% of the $4.41 billion portfolio of Soros Fund Management LLC. Kenneth Fisher owns 711,850 shares as of 09/30/2009, which accounts for 0.04% of the $29.78 billion portfolio of Fisher Asset Management, LLC. David Einhorn sold out his holdings in the quarter that ended on 09/30/2009.

No insiders have recently traded in the company, excluding its CEO.

Optimer Pharmaceuticals Inc. (OPTR, Financial): CEO and President Michael N Chang Bought 18,000 Shares

CEO and President of Optimer Pharmaceuticals Inc. (OPTR) Michael N Chang bought 18,000 shares on 12/29/2009 at an average price of $11.27. OPTIMER PHARMACEUTICALS, INC. is a biopharmaceutical company focused on discovering, developing & commercializing innovative anti-infective products for the treatment of serious infections. Optimer has a market cap of $373.2 million; its shares were traded at around $11.27 with and P/S ratio of 364.7.

Optimer recently reported its third quarter results. The company reported financial results for the third quarter ended September 30, 2009. Optimer reported a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2008 of $9.2 million, or $0.31 per share. Research and development expenses in the third quarter of 2009 were $7.2 million, compared to $7.9 million in the third quarter of 2008. shares were traded at around $11.15 with and P/S ratio of 360.8.

Buy:: COO and SVP Tessie M Che bought 18,000 shares of OPTR stock on 12/29/2009 at the average price of 10.83, the price of the stock has increased by 4.06% since. Many other insiders have also increased their positions in the company.

Keithley Instruments Inc. (KEI, Financial): Director, Chairman, CEO, 10% Owner Joseph P Keithley Bought 2,200 Shares

Director, Chairman, CEO, 10% Owner of Keithley Instruments Inc. (KEI) Joseph P Keithley bought 2,200 shares on 12/29/2009 at an average price of $4.65. Keithley Instruments Inc. develop, manufacture and sell measurementsystems geared to the specialized needs of electronics manufacturers forhigh-performance production testing, process monitoring, product development and research. The company has a market cap of $73.2 million; its shares were traded at around $4.65 with and P/S ratio of 0.7. The dividend yield of Keithley Instruments Inc. stocks is 1.1%.

Keithley recently released its 2009 annual report. The company announced that its net sales for 2009 were $102.5 million, compared with $152.5 million a year ago. The company reported a net loss of $51 million, compared to about $3 million a year ago.

Managers owns 1,416,918 shares as of 09/30/2009, which accounts for 0.05% of the $17.23 billion portfolio of NWQ Investment Management Co.

Buy:: Director James B Griswold bought 10,000 shares of KEI stock on 12/08/2009 at the average price of 4.33, the price of the stock has increased by 7.39% since.Sell:: Director Brian R Bachman sold 1,000 shares of KEI stock on 08/03/2009 at the average price of 5.85, the price of the stock has decreased by 20.51% since.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.